ScreenMe
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
ScreenMe is a femtech company that provides at-home microbiome testing and personalized health consultations for reproductive and intimate health.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, D2C Brands, Healthcare Analytics, Patient Engagement
Business Model
B2C
Customer Profile
Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ScreenMe Comparables
Compare ScreenMe with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vitall | 90% | |
| Forth | 88% | |
| Blue Horizon Blood Tests | 87% | |
ScreenMe Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 153% MoM, reaching 7.4K.
- Nov 7, 2025
Monthly visitors increased 235% MoM, reaching 11.5K.
ScreenMe Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ScreenMe's valuation, stock price, and market status.